Can AMD Be Reversed
The Short Answer for Each Type of AMD
Dry AMD, which accounts forapproximately 85-90% of all AMD cases, cannot be reversed with any current treatment, according to the NEI (2022) and AAO (2022). Structural damage to the retinal pigment epithelium and photoreceptors is generally irreversible once it occurs. All available treatments focus on slowing progression, not restoring lost tissue or vision.
Anti-VEGF intravitreal injections for wet AMD can halt abnormal blood vessel growth and, in many patients, produce measurable vision improvement. According to the AAO (2022) and NEI, landmark trials (ANCHOR, MARINA) showed that ranibizumab improved vision by15 or more letters in approximately 33-40% of patients. Starting treatment promptly after diagnosis gives the best chance of visual recovery. Delay reduces the likelihood of improvement.
AREDS2 supplements reduce the risk of progression from intermediate to advanced AMD byapproximately 25% over 5 yearsbut do not restore vision already lost, according to the NEI (2022). Two FDA-approved complement inhibitors for geographic atrophy (pegcetacoplan/Syfovre, approved February 2023; avacincaptad pegol/Izervay, approved August 2023) slow the growth of atrophic lesions but do not restore lost vision. These are preventive and slowing interventions, not restorative ones.
Current Treatments and What They Achieve
Your retinal specialist injects anti-VEGF medication directly into the eye to stop leaking blood vessels. Available drugs include ranibizumab, aflibercept, bevacizumab, and faricimab. Faricimab, a dual anti-VEGF/angiopoietin-2 inhibitor approved by the FDA in 2022, offers extended dosing intervals ofup to every 4 monthsand shows non-inferior visual outcomes, according to the AAO (2022). Most treated patients stabilize or improve their vision.
Pegcetacoplan and avacincaptad pegol are the first-ever approved treatments for late dry AMD. They work by blocking the complement immune pathway that drives inflammatory retinal damage. These drugs slow the expansion of atrophic lesions, according to the FDA and NEI (2023). They do not reverse damage or restore vision, but they reduce the rate at which geographic atrophy spreads.
In November 2024, the FDA cleared the Valeda Light Delivery System for dry AMD. Clinical data showed visual acuity improvement sustained up to24 monthsin intermediate dry AMD, according to FDA and BrightFocus (2024). This is the closest current option to functional vision improvement in dry AMD. Ask your retinal specialist whether you may be a candidate.
Emerging Therapies That Aim for Reversal
Gene therapy clinical trials for wet AMD are in progress. One therapy (SAR402663) received FDA Fast Track designation in September 2025 as a one-time treatment for wet AMD, according to NEI and FDA. Early-phase trials have demonstrated feasibility, but no gene therapy for AMD is commercially available yet. Gene therapy aims to deliver lasting benefit from a single injection rather than requiring ongoing treatment.
Researchers are testing whether transplanting healthy retinal pigment epithelium (RPE) cells can replace the cells that AMD destroys. According to the NEI, early-phase trials have demonstrated the feasibility of replacing lost RPE cells, though this approach is still experimental. A 2025 PMC review identified RPE cell transplantation as one of the most promising restorative strategies for AMD.
Risuteganib and elamipretide are drugs that stabilize mitochondrial function in retinal cells. According to AJMC (2023) and PMC (2025), early clinical trials showed potential to reverse some vision loss in intermediate dry AMD. These compounds are not yet FDA-approved but represent a new direction in AMD treatment that targets the cellular energy deficit behind retinal degeneration.
What You Can Do Now
If you are diagnosed with wet AMD, starting anti-VEGF treatment immediately gives you the best chance of vision stabilization and potential improvement. According to the AAO (2022) and NEI (2022), delay worsens outcomes. Contact your eye doctor immediately if you notice sudden distortion, a new blind spot, or rapid vision change in one eye.
If you have intermediate dry AMD, AREDS2 supplements, smoking cessation, a Mediterranean-style diet, and regular exercise can slow your progression. For geographic atrophy, ask your eye doctor about eligibility for complement inhibitor treatment. These strategies protect the vision you still have.
The AMD treatment landscape is evolving. Gene therapy, stem cell transplants, and mitochondrial stabilizers may offer true reversal in the coming years. Stay in regular follow-up with your retinal specialist to remain a candidate for emerging therapies as they move through clinical trials.
Questions About Reversing AMD
Anti-VEGF injections control wet AMD but do not cure it. Most patients require ongoing treatment to maintain their results. Stopping injections without your doctor guidance can allow the disease to reactivate.
Diet cannot reverse existing macular damage. A Mediterranean-style diet reduces inflammation and supports your remaining retinal tissue, which may slow further progression. Diet is a protective strategy, not a restorative one.
Stem cell treatments for AMD are in clinical trials and are not commercially available. Be cautious of clinics offering unproven stem cell therapies outside of clinical trials. These unregulated treatments carry serious risks, including vision loss.
Multiple research programs are actively pursuing reversal strategies. Photobiomodulation has shown functional improvement in intermediate dry AMD. Gene therapy and mitochondrial stabilizers are in clinical testing. The treatment pipeline for dry AMD is more active now than at any point in history.
Ask your retinal specialist about AMD clinical trials at your next appointment. You can also search clinicaltrials.gov for open studies. Eligibility depends on your AMD type, stage, and other health factors. Staying in regular follow-up positions you to learn about and join trials as they open.
Yes. AREDS2 supplements slow progression, which preserves the vision you have. Slowing AMD buys time for emerging therapies to become available. Continue your supplements as long as your eye doctor recommends them.
Protect What You Have
While no treatment fully reverses AMD today, prompt treatment for wet AMD can improve vision, and multiple research programs are pursuing true reversal. Work with your retinal specialist to use every available tool to slow progression and preserve your central vision.